Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation (Q44333462)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation
scientific article

    Statements

    Losartan reduces the costs associated with diabetic end-stage renal disease: the RENAAL study economic evaluation (English)
    William H Herman
    Shahnaz Shahinfar
    George W Carides
    Erik J Dasbach
    William C Gerth
    Charles M Alexander
    John R Cook
    William F Keane
    Barry M Brenner
    1 March 2003
    683-687

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit